In this webinar on using p16/Ki67 dual staining biomarkers in the triage of HPV-positive patients, experts from the United States and China share their experiences with these biomarkers in their routine clinical practices. As a gynaecological oncologist at UVA Health, Professor Leigh Cantrell emphasises that explaining the science behind HPV and its role in cervical […]
The Asia-Oceania Research Organisation in Genital Infection and Neoplasia (AOGIN) recently held its bi-annual conference in Seoul, South Korea, with the theme “Empowering Women, Together against Cervical Cancer”. Despite having many tools that can prevent, screen for and treat cervical cancer, the conference opened with a powerful statement: “Every two minutes, a woman dies of
Advancing women’s health: key takeaways from AOGIN 2024 Read More »
Speaking at EUROGIN 2024, Prof Dietmar Schmidt, Consultant Pathologist at MVZ Histology, Cytology and Molecular Diagnostics, talks about the benefits of using p16/Ki67 dual staining biomarkers as a predictor of risk for HPV-positive patients. Now with routine vaccination programmes being implemented alongside HPV primary screening in many countries, experts are looking to optimise the triage
In this webinar on optimising triage of HPV-positive patients with the use of p16/Ki67 dual staining biomarkers, two experts from Singapore General Hospital share their experiences with the use of this triage method. Prof Tay Sun Kuie, Clinical Professor and Senior Consultant OB/GYN and Dr Sangeeta Mantoo, Senior Consultant at the Department of Anatomical Pathology,
Optimising triage of HPV-positive patients with p16/Ki67 dual staining biomarkers Read More »
At the 35th International Papillomavirus Conference (IPVC) in April 2023, Prof Mark Stoler of the University of Virginia Health System spoke about detecting p16 and Ki-67, two biomarkers that indicate the presence of transforming HPV infections. His talk assesses their efficacy to definitively show the presence of HPV infection in a patient, showing how the
At the 35th International Papillomavirus Conference (IPVC) in April 2023, Dr Gino Venegas of the Department of Gynaecologic Oncology at the Angloamericana Clinic in Lima shares how Peru tackled cervical cancer by addressing numerous barriers to screening, such as lack of awareness, affordability challenges, limited political commitment to progress, and social stigma around HPV testing.
How Peru broke down barriers to cervical cancer screening Read More »
The World Health Organisation strongly encourages the use of digital technologies to support the cervical cancer elimination efforts that are underway in many countries around the world. At the 35th International Papillomavirus Conference (IPVC) in April 2023, Dr Luis Riba of Roche Diagnostics described how digital solutions can account for key challenges in cervical cancer
Co-creating digital solutions to support cervical cancer screening Read More »
As Vice President and Associate Chief Medical Officer at BioReference Laboratories, one of the largest clinical labs in the United States, Dr Tamera Paczos oversaw the addition of p16/Ki-67 dual staining assays to the lab’s assay portfolio. In the US, these assays are used in triage to further risk stratify women who have come for
Implementing p16/ki67 dual stain at a large US commercial lab: Dr Tamera Paczos Read More »
While cervical cancer is preventable, an estimated 14,000 new cases are diagnosed in the United States every year, leading to almost 4,300 deaths from the disease. As Professor Emeritus of Pathology and Clinical Gynaecology at the University of Virginia Health System, Prof Mark Stoler is working towards preventing these deaths. In this talk at the
Prof Mark Stoler on HPV primary screening with biomarker based triage Read More »
In 2020, the WHO announced its goal of eliminating cervical cancer by 2030. Its ‘90-70-90’ target was to ensure that 90% of girls would be fully vaccinated against HPV by 15 years old; 70% of women would be screened with a high-performance test by age 35 and again by 45; and 90% of women identified
APEC cervical cancer elimination: status report updates Read More »
Subscribe to Lab Insights latest news and update
Join over 3,000 HCPs receiving insights in their inbox every week.
